ADK and colorectal adenocarcinoma: The cytotoxic effects of these compounds were further evaluated in HT29 human colorectal adenocarcinoma cells, HepG2 human hepatoma cells and AML12 mouse hepatocytes, by measuring AK release after 24 h of compound incubation (Supplementary Fig. 15).